IRAK1 and hepatocellular carcinoma: In 2020, Chen and colleagues elucidated a mechanism by which IRAK1 promotes metastasis in hepatocellular carcinoma (HCC) through the activation of the NLRP3/MAPKs/IL-1β pathway [71].